Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?
about
A network biology approach to understanding the importance of chameleon proteins in human physiology and pathology.Continued EGFR-TKI with concurrent radiotherapy to improve time to progression (TTP) in patients with locally progressive non-small cell lung cancer (NSCLC) after front-line EGFR-TKI treatment.Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies.
P2860
Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Management of NSCLC Disease Pr ...... ssues and Potential Therapies?
@en
type
label
Management of NSCLC Disease Pr ...... ssues and Potential Therapies?
@en
prefLabel
Management of NSCLC Disease Pr ...... ssues and Potential Therapies?
@en
P2093
P2860
P50
P1433
P1476
Management of NSCLC Disease Pr ...... ssues and Potential Therapies?
@en
P2093
Giannis Mountzios
Lorenza Landi
Ourania Romanidou
P2860
P2888
P304
P356
10.1007/S40265-016-0578-Z
P577
2016-05-01T00:00:00Z
P6179
1019471356